ACE and COVID-19: Thus, in the context of the aforementioned SARS-CoV-2-induced ACE2 downregulation, it is likely that the increased levels of both Ang I and Ang II coming from visceral adipose tissue lead to an ACE/Ang II/AT1R “storm” affecting the pulmonary microcirculation in obese COVID-19 patients [37].